-
Restoration of miR-185 in combination with BCR-ABL downregulation by non-viral delivery of siRNA with lipomeric carriers and lipid nanoparticles sensitizes drug resistant cells to TKIs
Read MoreOver 130,000 people in Canada are living with and are actively being treated for bloodod cancers. The main problem with our available…
-
Athena Phoa
Primary Investigator
-
